High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.
about
Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplantAsparaginase pharmacology: challenges still to be faced.Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.A phase I study of CPI-613 in combination with high dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia.
P2860
High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
High dose cytarabine, mitoxant ...... leukemia (AML) in the elderly.
@ast
High dose cytarabine, mitoxant ...... leukemia (AML) in the elderly.
@en
type
label
High dose cytarabine, mitoxant ...... leukemia (AML) in the elderly.
@ast
High dose cytarabine, mitoxant ...... leukemia (AML) in the elderly.
@en
prefLabel
High dose cytarabine, mitoxant ...... leukemia (AML) in the elderly.
@ast
High dose cytarabine, mitoxant ...... leukemia (AML) in the elderly.
@en
P2093
P2860
P1433
P1476
High dose cytarabine, mitoxant ...... leukemia (AML) in the elderly.
@en
P2093
Bayard L Powell
Dmitriy Berenzon
Heidi D Klepin
Leslie R Ellis
Megan Manuel
Sarah Dralle
Scott Holwerda
Scott Isom
Susan Lyerly
Tamjeed Ahmed
P2860
P304
P356
10.1016/J.LEUKRES.2015.05.010
P577
2015-06-01T00:00:00Z